ALPS Medical Breakthroughs ETF Rating $30.96 +0.15 (+0.49%) As of 01/17/2025 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatings ALPS Medical Breakthroughs ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.SBIO Aggregate RatingModerate Buy 2.90Holdings in SBIO have an aggregate rating of Moderate Buy based on 443 analyst ratings issued in the past year covering 50 companies (84.3% of the portfolio).SBIO Aggregate Price Target$30.96High Prediction$30.96Average Prediction$30.96Low Prediction$30.96Holdings in SBIO have an aggregate price target of $30.96 and a range of $30.96 to $30.96 covering 50 companies (84.3% of the portfolio).SBIO Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy31 Buy rating(s)Moderate Buy16 Moderate Buy rating(s)Hold2 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by ALPS Medical Breakthroughs ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 50 SBIO Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings3.75%ALKSAlkermes$29.47-0.9%4.5126 of 5 stars2.64$36.00 22.2%11Short Interest ↓3.20%AXSMAxsome Therapeutics$91.93-1.9%4.6768 of 5 stars3.00$130.69 42.2%13Analyst Revision3.11%CRNXCrinetics Pharmaceuticals$37.35+2.4%3.7053 of 5 stars3.00$74.40 99.2%10Short Interest ↑3.05%VRNAVerona Pharma$51.89-3.3%2.0679 of 5 stars3.13$50.57 -2.5%82.90%RNAAvidity Biosciences$28.92+2.2%1.0998 of 5 stars3.00$65.80 127.5%102.85%RYTMRhythm Pharmaceuticals$54.54-0.2%4.2179 of 5 stars2.91$68.09 24.8%11Positive News2.80%PTCTPTC Therapeutics$43.84+1.8%4.4835 of 5 stars2.47$55.00 25.5%15Analyst RevisionHigh Trading Volume2.48%MRUSMerus$39.45-0.5%3.0469 of 5 stars3.14$85.64 117.1%142.42%XENEXenon Pharmaceuticals$38.52-2.8%2.7564 of 5 stars3.13$56.00 45.4%8Positive News2.42%VCELVericel$59.07+4.8%1.926 of 5 stars3.00$62.14 5.2%7Analyst Revision2.41%MLTXMoonLake Immunotherapeutics$43.81+5.6%1.9821 of 5 stars3.00$84.29 92.4%8Analyst UpgradeGap UpHigh Trading Volume2.37%ACADACADIA Pharmaceuticals$17.57+0.3%4.0907 of 5 stars2.59$25.25 43.7%17Short Interest ↑2.28%ZLABZai Lab$26.05+2.6%2.7048 of 5 stars3.00$55.00 111.1%32.27%DNLIDenali Therapeutics$21.93+1.2%4.3872 of 5 stars2.93$38.91 77.4%14Short Interest ↑2.22%FOLDAmicus Therapeutics$9.41+0.5%4.3809 of 5 stars2.78$16.88 79.3%91.94%VERAVera Therapeutics$33.37+1.8%2.323 of 5 stars3.11$63.50 90.3%91.90%NAMSNewAmsterdam Pharma$23.55+0.6%2.9224 of 5 stars3.00$39.80 69.0%61.89%EWTXEdgewise Therapeutics$26.26-1.7%2.1412 of 5 stars3.00$43.17 64.4%6Short Interest ↑Positive NewsGap Down1.80%PTGXProtagonist Therapeutics$36.82+0.8%3.0668 of 5 stars3.00$53.78 46.1%91.71%IDYAIDEAYA Biosciences$22.18-2.4%3.9911 of 5 stars2.94$53.67 142.0%16Short Interest ↑1.69%CGONCG Oncology$29.08-0.1%1.1711 of 5 stars3.10$63.88 119.7%101.66%TARSTarsus Pharmaceuticals$46.52-0.9%1.8305 of 5 stars3.00$54.20 16.5%61.64%MIRMMirum Pharmaceuticals$46.95+2.4%4.0314 of 5 stars3.09$57.10 21.6%111.62%AGIOAgios Pharmaceuticals$32.42+1.9%3.7363 of 5 stars2.50$56.33 73.8%8Short Interest ↑1.53%APGEApogee Therapeutics$37.06+1.0%2.3752 of 5 stars3.00$89.71 142.1%71.46%IRONDisc Medicine$58.24-2.9%2.6804 of 5 stars3.10$87.50 50.2%10Short Interest ↑1.43%AKROAkero Therapeutics$25.14+4.7%3.9363 of 5 stars2.88$46.83 86.3%81.40%GLPGGalapagos$23.76-0.6%1.3897 of 5 stars1.63$30.75 29.4%81.39%MNKDMannKind$6.013.7526 of 5 stars3.13$9.07 50.9%8News Coverage1.38%VIRVir Biotechnology$10.11+0.6%4.2004 of 5 stars2.83$34.83 244.5%6Positive News1.33%CLDXCelldex Therapeutics$23.78+4.5%1.589 of 5 stars2.88$62.25 161.8%8Short Interest ↑Positive News1.31%BCRXBioCryst Pharmaceuticals$7.45+5.5%4.3471 of 5 stars2.83$15.17 103.6%6Short Interest ↓High Trading Volume1.26%IMCRImmunocore$29.02-0.3%2.4673 of 5 stars2.54$65.64 126.2%131.23%NVAXNovavax$8.40-1.5%4.0134 of 5 stars2.33$17.83 112.3%6Gap Down1.19%GPCRStructure Therapeutics$27.06+0.3%1.5786 of 5 stars3.00$81.29 200.4%8Short Interest ↑1.19%VRDNViridian Therapeutics$18.13+6.3%2.0338 of 5 stars2.75$35.70 96.9%121.19%XNCRXencor$19.24-3.9%4.1024 of 5 stars3.11$36.56 90.0%9Positive News1.07%RCUSArcus Biosciences$13.99-0.9%1.8822 of 5 stars3.00$34.00 143.0%90.98%DAWNDay One Biopharmaceuticals$12.54+1.1%1.9964 of 5 stars3.00$35.86 185.9%9News Coverage0.97%PRAXPraxis Precision Medicines$70.54+0.4%1.8854 of 5 stars2.89$146.33 107.4%90.95%AUPHAurinia Pharmaceuticals$8.01+3.5%2.3116 of 5 stars2.75$10.00 24.8%4Positive News0.86%NTLAIntellia Therapeutics$9.50+0.8%4.4841 of 5 stars2.72$51.06 437.5%180.85%LQDALiquidia$12.89+3.0%2.9182 of 5 stars3.11$25.38 96.9%90.79%AVXLAnavex Life Sciences$9.21-9.3%3.6968 of 5 stars3.33$44.00 377.7%30.79%PHVSPharvaris$18.36+5.2%2.5567 of 5 stars3.00$39.25 113.8%4Positive NewsGap Down0.77%NUVBNuvation Bio$2.51-1.4%2.2545 of 5 stars3.00$7.40 195.4%5Gap Down0.69%REPLReplimune Group$10.14-2.1%4.1212 of 5 stars3.13$17.29 70.5%80.69%AVBPArriVent BioPharma$24.41-0.3%1.3658 of 5 stars3.00$36.80 50.8%5Short Interest ↑0.61%UPBUpstream Bio$11.00+1.1%N/A3.00$56.50 413.6%40.60%PLRXPliant Therapeutics$11.21-3.4%3.767 of 5 stars3.13$40.50 261.3%8 This page (NYSEARCA:SBIO) was last updated on 1/20/2025 by MarketBeat.com Staff From Our PartnersLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | SponsoredMust-See: 5-Second Trump PredictionPresident Trump's prediction is about to become a reality... Opening a rare window of opportunity for you t...InvestorPlace | SponsoredBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredWarren Buffett Bets $40 Billion—You Can Get in for $20I call it "The Last Retirement Stock You'll Ever Need." Warren Buffett himself owns $40 billion of stock in...Behind the Markets | SponsoredKamala’s final humiliation The investments connected to Trump's second term in ways that almost nobody outside his inner circle is aware ...Porter & Company | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ALPS Medical Breakthroughs ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share ALPS Medical Breakthroughs ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SBIO Stock Alerts